Inventor · disambiguated record
Rogier Christian Buijsman
Also filed as: BUIJSMAN ROGIER CHRISTIAN
9 granted patents·2 pending applications·29 citations·filing 1999–2022
81Inventor score
Files withNETHERLANDS TRANSLATIONAL RES CENTER B V6AKZO NOBEL NV1CROSSFIRE ONCOLOGY HOLDING B V1MAN PETRUS ANTONIUS DE ADRIANUS1PLATE RALF1
Top patents by PatentIndex Score
11 records- 0173US7576071B2Antithrombotic compoundSANOFI AVENTIS·Filed 2006·Granted Aug 18, 2009·2 cites·4 claims
- 0271USRE48974E(5,6-dihydro)pyrimido[4,5-E]indolizinesNETHERLANDS TRANSLATIONAL RES CENTER B V·Filed 2015·Granted Mar 15, 2022·1 cites·25 claims
- 0367US10494360B2Inhibitors of indoleamine 2,3-dioxygenaseNETHERLANDS TRANSLATIONAL RES CENTER B V·Filed 2017·Granted Dec 3, 2019·1 cites·15 claims
- 0467US8133885B2Non steroidal glucocorticoid receptor modulatorsPLATE RALF·Filed 2006·Granted Mar 13, 2012·2 cites·11 claims
- 0562US6486129B1Antithrombotic compoundsAKZO NOBEL NV·Filed 1999·Granted Nov 26, 2002·23 cites·9 claims
- 0652USRE50082E(5,6-dihydro)pyrimido[4,5-e]indolizinesNETHERLANDS TRANSLATIONAL RES CENTER B V·Filed 2015·Granted Aug 20, 2024·0 cites·21 claims
- 0752US2025074911A1Macrocyclic btk inhibitorsCROSSFIRE ONCOLOGY HOLDING B V·Filed 2022·Application pending·0 cites
- 0844US9856258B2(5,6-dihydro)pyrimido[4,5-E]indolizinesNETHERLANDS TRANSLATIONAL RES CENTER B V·Filed 2015·Granted Jan 2, 2018·0 cites·13 claims
- 0940US11053230B23-hydroxy-imidazolidin-4-one compounds as inhibitors of indoleamine 2,3-dioxygenaseNETHERLANDS TRANSLATIONAL RES CENTER B V·Filed 2018·Granted Jul 6, 2021·0 cites·17 claims
- 1037US2014155406A14-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides btk inhibitorsMAN PETRUS ANTONIUS DE ADRIANUS·Filed 2012·Application pending·0 cites
- 1136US10689343B2Inhibitors of tryptophan 2,3-dioxygenaseNETHERLANDS TRANSLATIONAL RES CENTER B V·Filed 2017·Granted Jun 23, 2020·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Rogier Christian Buijsman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →